• Latest
    • Big pharma
    • Biotechnology
    • CRISPR
    • Generics
    • Unified Patent Court
  • Regions
    • Americas
    • Europe
    • Asia
    • Asia-Pacific
  • Careers
  • Events
    • Conferences
    • Conference Videos
    • Webinars
  • Directory
  • Magazines
  • About
  • Contact
  • Newsletter
  • Login
  • Subscribe
  • Home
  • About
  • Contact
  • Newsletter
  • Login


Subscribe
  • Home
  • Search Results

Search Results

Reset all filters
Channel
Geography
Company
Refine Search

News & Features

Commercialising genomic tech in Nigeria
Africa
Commercialising genomic tech in Nigeria
Genomic innovations involve vast amounts of research, making patents, copyrights, and trade secrets vital, explains Olusola Tunmise-Ajani of Inventa International.   29 April 2025
How post-filing data rescued Novo Nordisk’s Ozempic patent in China
Asia
How post-filing data rescued Novo Nordisk’s Ozempic patent in China
The Beijing IP court’s decision to revive a key semaglutide patent based on experimental data has far-reaching legal and economic implications, says Jennifer Che of Eagle IP   15 October 2024
How to navigate patent term adjustment in China
Asia
How to navigate patent term adjustment in China
Recent updates to China’s patent law provide guidelines on PTA calculations, definitions of delays and challenging decisions, say Audrey Cheung, Yolanda Wang and Jennifer Che of Eagle IP.   8 October 2024
Americas
‘Masking only works for so long’: Working with ADHD
Being a lawyer with ADHD is far from easy due to widespread misconceptions about the condition but there are ways to offer support, says Lisa Mueller of Casimir Jones.   1 August 2024
Big Pharma
Amgen v Sanofi/Regeneron in Japan: Function, sequence, mechanism
Amgen patents declared valid in Germany and Japan have also been deemed invalid by the European Patent Office, US Supreme Court, and in a separate Japan decision: but why? Takanori Abe of Abe & Partners examines the details.   19 March 2024
Americas
UKIPO rejects Boehringer’s SPC for horse inhaler
Office declined application, citing earlier authorisations for inhalers designed for people containing the same ingredient | Boehringer argued that ciclesonide was a ‘new active substance’ not previously authorised for a veterinary product in the EU.   8 July 2025
Americas
WilmerHale gains partner with ‘deep expertise’
New addition expected to strengthen firm’s foundational ‘IP’ practice in Palo Alto.   8 July 2025
Americas
Bayer, Orion take on Indian generic over $117bn drug
German and Finnish pharma giants sue Indian rival in Delaware court | Dispute centres on generic bid for prostate cancer blockbuster | Suit follows leadership shakeup at Bayer.   8 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
The architect of an historic change in the way patent claims are interpreted explains what it means for AI drafting, and why more harmonisation may follow, reports Tom Phillips   3 July 2025
Europe
BMS unit loses cell therapy patent at European Patent Office
Board of Appeal upholds opposition challenge over added subject-matter claims | Dispute concerned patent relating to T cell therapeutic manufacturing methods.   3 July 2025
Load More

Companies

company
Appleyard Lees European Patent & Trade Mark Attorneys
company
Dechert LLP
company
Kaye Scholer
company
Kilpatrick Townsend
company
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo
company
Powell Gilbert LLP
company
WilmerHale
company
Nutter McClennen & Fish
company
O’Melveny & Myers LLP
  • Home
  • News
  • About us
  • Contact
  • Terms of Use
  • Privacy Policy
  • Terms of Subscription

LSIPR
Newton Media Ltd
Kingfisher House
21-23 Elmfield Road
BR1 1LT
United Kingdom

  • Twitter
  • Linkedin